Author:
Dosne Anne-Gaëlle,Bergstrand Martin,Harling Kajsa,Karlsson Mats O.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Lalonde RL, Kowalski KG, Hutmacher MM, Ewy W, Nichols DJ, Milligan PA, Corrigan BW, Lockwood PA, Marshall SA, Benincosa LJ, Tensfeldt TG, Parivar K, Amantea M, Glue P, Koide H, Miller R (2007) Model-based drug development. Clin Pharmacol Ther 82(1):21–32. doi: 10.1038/sj.clpt.6100235
2. Jonsson EN, Sheiner LB (2002) More efficient clinical trials through use of scientific model-based statistical tests. Clin Pharmacol Ther 72(6):603–614. doi: 10.1067/mcp.2002.129307
3. Kraiczi H, Frisen M (2005) Effect of uncertainty about population parameters on pharmacodynamics-based prediction of clinical trial power. Contemp Clini Trials 26(2):118–130. doi: 10.1016/j.cct.2004.10.002
4. Santen G, Danhof M, Pasqua OD (2008) Uncertainty and decision making in clinical development: the impact of an interim analysis based on the posterior predictive power on depression trials. http://tucson2008.go-acop.org/pdfs/DellaPasqua2.pdf . Accessed 16 Mar 2015
5. Waterhouse T, Benson C, Chiang A, Tang C (2009) Using uncertainty in exposure-response modeling and simulation to select phase II doses. http://2009.go-acop.org/sites/all/assets/webform/Waterhouse%20ACOP%202009%20poster.pdf . Accessed 2015 Mar 16
Cited by
197 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献